781 related articles for article (PubMed ID: 7594088)
1. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure.
Gogia H; Mehra A; Parikh S; Raman M; Ajit-Uppal J; Johnson JV; Elkayam U
J Am Coll Cardiol; 1995 Dec; 26(7):1575-80. PubMed ID: 7594088
[TBL] [Abstract][Full Text] [Related]
2. Prevention of nitrate tolerance with concomitant administration of hydralazine.
Elkayam U
Can J Cardiol; 1996 May; 12 Suppl C():17C-21C. PubMed ID: 8634919
[TBL] [Abstract][Full Text] [Related]
3. The effect of hydralazine on the development of tolerance to continuous nitroglycerin.
Parker JD; Parker AB; Farrell B; Parker JO
J Pharmacol Exp Ther; 1997 Feb; 280(2):866-75. PubMed ID: 9023301
[TBL] [Abstract][Full Text] [Related]
4. [Hemodynamic effect of molsidomine in coronary patients with heart failure with clinically manifest nitrate tolerance].
Störk T; Möckel M; Störk S; Piske G; Danne O; Bodemann T; Müller R; Eichstädt H; Hochrein H
Z Kardiol; 1993 May; 82(5):293-301. PubMed ID: 8328179
[TBL] [Abstract][Full Text] [Related]
5. [8-hour hemodynamic study of 2 sustained-release nitrate derivatives. Comparative double-blind study against placebo].
Dubourg O; Guéret P; Ferrier A; Léger P; Farcot JC; Rigaud M; Beaumont D; Bardet J; Bourdarias JP
Arch Mal Coeur Vaiss; 1983 Feb; 76(2):211-9. PubMed ID: 6407429
[TBL] [Abstract][Full Text] [Related]
6. Prevention and reversal of nitrate tolerance in patients with congestive heart failure.
Packer M; Lee WH; Kessler PD; Gottlieb SS; Medina N; Yushak M
N Engl J Med; 1987 Sep; 317(13):799-804. PubMed ID: 3114637
[TBL] [Abstract][Full Text] [Related]
7. [The acute, chronic continuous after treatment and chronic intermittent with a variable therapeutic window (4 and 6 hours) hemodynamic effects induced with transdermal nitroglycerin in patients with congestive heart failure].
Nodari S; Metra M; Gei P; Danesi R; Furloni R; Cuminetti S; Dei Cas L
Cardiologia; 1991 Jun; 36(6):451-60. PubMed ID: 1769029
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic effects of intravenous sematilide in patients with congestive heart failure: a class III antiarrhythmic agent without cardiodepressant effects.
Stambler BS; Gottlieb SS; Singh BN; Ramanathan KB; Ogilby JD; Ellenbogen KA
J Am Coll Cardiol; 1995 Dec; 26(7):1679-84. PubMed ID: 7594103
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic effect of recombinant human brain natriuretic peptide for treatment of decompensated heart failure: comparison with nitroglycerin].
Xie CL; Meng SR; Wang W; Chen SM; Li P; Feng XG
Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):839-42. PubMed ID: 18504215
[TBL] [Abstract][Full Text] [Related]
10. Captopril does not prevent nitroglycerin tolerance in heart failure.
Dupuis J; Lalonde G; Bichet D; Rouleau JL
Can J Cardiol; 1990 Sep; 6(7):281-6. PubMed ID: 2121325
[TBL] [Abstract][Full Text] [Related]
11. [Dose and time dependence of hemodynamic tolerance development during intravenous nitrate therapy in acute myocardial infarct].
Meissner A; Schulte HM; Herrmann G; Walek T; Höfig M; Simon R
Z Kardiol; 1991 Apr; 80(4):279-85. PubMed ID: 1907422
[TBL] [Abstract][Full Text] [Related]
12. [Randomized, double-blind, placebo-controlled study of supplemental vitamin E on attenuation of the development of nitrate tolerance].
Watanabe H; Kakihana M; Ohtsuka S; Sugishita Y
J Cardiol; 1998 Mar; 31(3):173-81. PubMed ID: 9557281
[TBL] [Abstract][Full Text] [Related]
13. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
Givertz MM; Hare JM; Loh E; Gauthier DF; Colucci WS
J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
[TBL] [Abstract][Full Text] [Related]
14. [The advantageous effects of a prolonged intravenous load with a nitroglycerin solution on the lesser circulation in patients with chronic heart failure].
Kazeĭ DV; Mareev VIu
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1988; 11(2):27-34. PubMed ID: 3148308
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamic characterization of tolerance to long-term hydralazine therapy in severe chronic heart failure.
Packer M; Meller J; Medina N; Yushak M; Gorlin R
N Engl J Med; 1982 Jan; 306(2):57-62. PubMed ID: 7053487
[TBL] [Abstract][Full Text] [Related]
16. [Hemodynamic response to high-dose nitroglycerin infusion in patients with severe heart failure after pretreatment and clinical stabilization].
Faggiano P; Rusconi C
G Ital Cardiol; 1991 Nov; 21(11):1195-202. PubMed ID: 1809623
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the acute hemodynamic effects of inhaled nitroglycerin and iloprost in patients with pulmonary hypertension undergoing mitral valve surgery.
Yurtseven N; Karaca P; Uysal G; Ozkul V; Cimen S; Tuygun AK; Yuksek A; Canik S
Ann Thorac Cardiovasc Surg; 2006 Oct; 12(5):319-23. PubMed ID: 17095973
[TBL] [Abstract][Full Text] [Related]
18. Concurrent hydralazine administration prevents nitroglycerin-induced hemodynamic tolerance in experimental heart failure.
Bauer JA; Fung HL
Circulation; 1991 Jul; 84(1):35-9. PubMed ID: 1905595
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure.
Massie B; Chatterjee K; Werner J; Greenberg B; Hart R; Parmley WW
Am J Cardiol; 1977 Nov; 40(5):794-801. PubMed ID: 411364
[TBL] [Abstract][Full Text] [Related]
20. Randomized study to evaluate the relation between oral isosorbide dinitrate dosing interval and the development of early tolerance to its effect on left ventricular filling pressure in patients with chronic heart failure.
Elkayam U; Roth A; Mehra A; Ostrzega E; Shotan A; Kulick D; Jamison M; Johnston JV; Rahimtoola SH
Circulation; 1991 Nov; 84(5):2040-8. PubMed ID: 1934379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
